Welcome & Introduction by the Chair of BHIVA
Yvonne Gilleece
Brighton & Sussex University Hospitals NHS Trust
Navigating new pandemics: what have we learnt
Susan Hopkins
UK Health Security Agency
Of Pandemics and Wars
Sanjay Bhagani
Royal Free London NHS Foundation Trust, UK
HIV and Resistance
Public health approach to HIV treatment and the impact of drug resistance
Nick Paton, National University of Singapore
Highly Treatment Experienced: what it means & best management
Laura Waters, Mortimer Market Centre, London
Oral abstracts session one
O01 Microelimination of hepatitis C among people living with diagnosed HIV in England
James Lester, UK Health Security Agency, UK
O02 Laboratory implementation of Emergency Department BloodBorne Virus (EDBBV) opt out screening in a London tertiary centre
Jennifer Hart, Royal Free London NHS Foundation Trust, UK
O03 A review of sexual health and blood borne virus care provided to inmates at admission into UK prisons and secure facilities
Natasha Bell, Imperial College Healthcare NHS Trust, UK
O04 Implementation of routine opt-out Blood Borne Virus (BBV) screening in 34 Emergency Departments (EDs) in areas of extremely HIV prevalence in England
Rachel Hill-Tout, NHS England, UK
O05 Impact and experiences of offering HIV testing across the whole city population through primary care clusters and GP surgeries in the Texting 4 Testing (T4T) project
Darren Cousins, Fast Track Cities Cardiff & Vale, UK
Parallel session - Building international partnerships online and in person: lessons from Indonesia and Nigeria
Building international partnerships online and in person: lessons from Indonesia and Nigeria
Keerti Gedela
Chelsea and Westminster Hospital NHS Foundation Trust
Tomilola Musari-Martins
Nigerian Institute of Medical Research, Lagos, Nigeria (remote speaker)
Parallel session - Implementation of routine opt-out Blood Borne Virus (BBV) screening in Emergency Departments (EDs)
Rachel Hill-Tout
NHS England
Orla McQuillan
Manchester Foundation Trust
Ian Jackson
NHS England
Stephen Hindle
NHS England
Oral abstracts session two
O06 'Not PrEPared' – Barriers to accessing PrEP in England
Adam Freedman, National AIDS Trust, UK
O07 HIV care during the SARSCOV-2 pandemic in black people with HIV in the UK
Zoe Ottaway, Kings College Hospital NHS Foundation Trust, UK
O08 Clinical presentation of mpox in people with and without HIV
Michael Brady, King's College Hospital NHS Foundation Trust, UK
O09 “If you don’t know, how can you know?”: A qualitative investigation of HIV Pre-exposure prophylaxis knowledge and perceptions among women in England
Melissa Cabecinha, University College London, UK
O10 Sexually acquired young adults with HIV - a neglected cohort?
Sophie Herbert, Northamptonshire Healthcare NHS Foundation Trust, UK
Clinico-pathological case presentations
Case One - The hard cell: difficult diagnostics in a complex case
Meredith Moodie, North Middlesex University Hospital NHS Trust
Case Two - An unusual cause of headache
Nivenjit Kaur, King’s College Hospital NHS Trust
Case Three - Vanishing Bile Duct Syndrome
Kinjal Patel, Imperial College Healthcare NHS Trust/ Chelsea and Westminster Hospital NHS Foundation Trust
Case Four - Disseminated infection with new onset of neurological symptoms in a newly diagnosed HIV patient
Wai Lin Htun, Blackpool Teaching Hospital NHS Foundation Trust
The Care Cascade: where should we focus next?
Overview of the cascade: where should we focus next?
Ann Sullivan, Chelsea and Westminster Hospital NHS Foundation Trust, UK
People living with HIV not in care: time to act!
Kate Childs, Kings College Hospital, UK
People living with HIV not in care: how can the data help?
Veronique Martin, UK Health Security Agency (UKSHA)
PROMs
An overview of patient-reported outcome measures
Diana Barger, University of Bordeaux, France
Evidence for PROMs in HIV care
Daniella Chilton, Guy's and St Thomas' NHS Foundation Trust, UK
The use of PROMs in clinical trials
Professor Caroline Sabin, University College London, UK
Embedding PROMs in BHIVA standards, what needs to happen
Fiona Burns, University College London / Royal Free Hospital, UK
Oral abstracts session three
O11 Diabetes and hypertensive disorders in pregnant women living with HIV in the UK and Ireland
Laurette Bukasa, Integrated Screening Outcomes Surveillance Service (ISOSS), UK
O12 Monitoring clinical practice of BHIVA supported breastfeeding guidelines for women living with HIV in the UK
Rebecca Sconza, Integrated Screening Outcomes Surveillance Service (ISOSS), UK
O13 Antiretroviral therapy (ART) inhibits the growth of cervicovaginal microbiome species in vitro: potential role in preterm birth (PTB)
Veronica Georgiana Preda, Imperial College London, UK
O14 Comparison of pregnancy outcomes for mothers living with perinatally acquired HIV, behaviourally acquired HIV, and those not living with HIV
Shivani Shah, Imperial College Healthcare NHS Trust, UK
O15 High-risk HPV prevalence and serostatus in women living with perinatally acquired HIV (the SHiP study)
Tamara Elliott, Imperial College London, UK
Parallel session - Tablet tales - myths, misconceptions and other patient questions
Tablet tales - myths, misconceptions and other patient questions
Ewan Hunter
The Newcastle-upon-Tyne Hospitals NHS Foundation Trust, UK
Becky Walker
Blue Sky Trust, UK
Mark Ellerby-Hedley
Newcastle upon Tyne Hospitals, UK
Parallel session - Syphilis: Still Surprising Us
Victoria Appleby
Leeds Teaching Hospitals, UK
Kate Flanagan
King’s College London, UK
Oral abstracts session four
O16 Lenacapavir with bNAbs teropavimab (3BNC117-LS) and zinlirvimab (10-1074-LS) dosed every 6 months in people with HIV
Neal Marshall, Gilead Sciences Ltd, London, UK
O17 Rate of persistent depressive symptoms among participants in the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study
Hajra Okhai, University College London, UK
O18 Prevalence of transmitted drug resistance among adults newly diagnosed with a recent HIV infection: a national survey
Anna Maria Geretti, University of Rome Tor Vergata, Italy
O19 Waist circumference cut-offs for metabolic syndrome and insulin resistance in women and men of African ancestry living with HIV
Laura Ribeiro Cechin, King's College Hospital NHS Foundation Trust, UK
O20 Eligibility for long acting cabotegravir/ rilpivirine in youth aged 12-25 living with perinatallyacquired HIV
Sara Ayres, Imperial College Healthcare NHS Trust, UK
Longer-term safety of integrase inhibitors
Andrew Carr
St Vincent’s Hospital, Sydney, Australia
Themed Poster session
TP01 Blueteq is not just about cost, it’s an opportunity to optimise antiretroviral therapy
Sinead Peare, Guy's and St Thomas' NHS Foundation Trust, UK
TP02 Opportunities to improve optout blood-borne virus screening in two large London Emergency Departments
Cassandra Fairhead, Royal Free London NHS Foundation Trust, UK
TP03 Patient evaluation of Klick, a technology enabled, nurse delivered HIV outpatient pathway
Caroline Rae, Chelsea and Westminster Hospital, UK
TP04 An innovative, patient centered approach to delivery of long-acting injectable antiretroviral therapy to people living with HIV using pre-existing outpatient parenteral antimicrobial therapy (OPAT) services
Bazga Ali, Public Health Wales, Cardiff, UK
TP05 Addressing the Workforce Challenge: Role of the Advanced Pharmacist Practitioner (APP)
Hasan Mohammed, Chelsea & Westminster Hospital NHS Foundation Trust, UK
TP06 Integrating peer support within NHS clinics - a London Fast-Track Cities Initiative (FTCI) project
Garry Brough, Positively UK
Providing mental health care and wellbeing in HIV: Learnings from the field
Updating the Standards for Psychological Support for Adults Living with HIV: Results of the stakeholder pre-consultation
Sarah Rutter, Manchester University NHS Foundation Trust, UK & Hajra Okhai, University College London, UK
Recent updates in the provision of addiction treatment
Andrea Hearn, Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK
BHIVA Equality, Equity, Diversity and Inclusion Session
BHIVA Equality, Equity, Diversity and Inclusion Session
Background to EEDI work
Rageshri Dhairyawan, Barts Health NHS Trust, UK
BHIVA: Equity, Equality, Diversity and Inclusion Review Update
Melvina Woode Owusu, Purple Pen Research and Evaluation Consulting, UK
Plan of action and future work
Tristan Barber, Royal Free London NHS Foundation Trust
Parallel session - Sharing from Chiva oral history project 'Positively Spoken'
Wendy Rickard and Ruth Mukonoweshuro
Chiva
Parallel session - People living with HIV not in care: logistics and disclosure
Lucy Wood
Lewisham and Greenwich NHS Trust, UK
Rose Mower
Guy's & St Thomas' Hospital NHS Trust, UK
Hannah Alexander
North Middlesex University Hospital NHS Trust, UK
Melanie Rosenvinge
Lewisham and Greenwich NHS Trust, UK
Parallel session - Reviewing papers: what to look for in Real-World Evidence (RWE) studies?
Caroline Sabin
University College London, UK
Clinical session
Absolute risk and benefits of interventions related to cardiovascular disease
Neil Poulter, Imperial College London, UK
Malignancy – what’s new in lung cancer?
Qamar Ghafoor, University Hospitals Birmingham NHS Foundation Trust, UK